CVS Health Corporation $CVS Shares Sold by Stablepoint Partners LLC

Stablepoint Partners LLC lowered its holdings in CVS Health Corporation (NYSE:CVS) by 7.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 91,861 shares of the pharmacy operator’s stock after selling 7,549 shares during the period. CVS Health accounts for 1.1% of Stablepoint Partners LLC’s investment portfolio, making the stock its 22nd biggest position. Stablepoint Partners LLC’s holdings in CVS Health were worth $6,925,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. CFS Investment Advisory Services LLC acquired a new position in shares of CVS Health during the 3rd quarter valued at $336,000. Vanguard Personalized Indexing Management LLC increased its holdings in CVS Health by 2.6% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 155,246 shares of the pharmacy operator’s stock worth $11,704,000 after purchasing an additional 4,006 shares during the last quarter. Callahan Advisors LLC raised its holdings in CVS Health by 15.9% in the third quarter. Callahan Advisors LLC now owns 88,808 shares of the pharmacy operator’s stock valued at $6,695,000 after acquiring an additional 12,158 shares in the last quarter. Avantax Planning Partners Inc. bought a new position in shares of CVS Health during the third quarter worth about $200,000. Finally, WealthShield Partners LLC acquired a new position in shares of CVS Health in the 3rd quarter worth approximately $218,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Neutral Sentiment: Analyst coverage and stock-forecast pages are drawing attention but contain mixed signals rather than a clear catalyst; investors are watching updates to models and consensus estimates. CVS Health Corporation (CVS) Stock Forecasts
• Neutral Sentiment: Media coverage and analyst write-ups note CVS as a trending name — highlighting investor interest but not providing a definitive directional driver by itself. CVS Health Corporation (CVS) Is a Trending Stock
• Negative Sentiment: The Trump administration proposed keeping Medicare Advantage payment rates roughly flat next year (around a 0.09% average increase), which directly pressures revenue and margin expectations for insurers and plan sponsors — including CVS’s Medicare business (Aetna). That proposal triggered steep sell-offs in major health insurers and was cited as the main reason for sharp share weakness in after-hours trading. Trump Administration proposes keeping steady Medicare rates paid to insurers, WSJ reports Health insurers tumble after Trump administration proposes keeping Medicare Advantage rates flat next year Humana, UnitedHealth, and CVS Stocks Plunge After Medicare Rates Blow
• Negative Sentiment: Congressional investigators allege CVS used contracting and platform tactics to shut out competing pharmacy hubs, drawing House Judiciary attention and adding antitrust/regulatory risk. That kind of regulatory scrutiny can lead to fines, remedies, or business restrictions that would pressure longer-term growth and valuations. CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation House report alleges CVS aimed to stifle pharmacy hub competition
• Neutral Sentiment: Local and trade coverage highlights CVS’s ongoing fights with regulators (FTC, Congress) while it positions itself as a partner in healthcare reform — a reminder that strategy and legal/regulatory noise will remain part of the stock’s narrative. Woonsocket-based CVS battles Congress, FTC and courts while positioning itself as healthcare reform partner

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CVS. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Sanford C. Bernstein restated a “market perform” rating and set a $91.00 price target on shares of CVS Health in a research report on Tuesday, January 6th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Barclays raised their target price on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday, December 10th. Finally, Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $94.86.

CVS Health Stock Performance

Shares of CVS Health stock opened at $83.97 on Tuesday. CVS Health Corporation has a twelve month low of $53.36 and a twelve month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The stock has a market cap of $106.59 billion, a price-to-earnings ratio of 220.98, a P/E/G ratio of 0.76 and a beta of 0.48. The company’s fifty day moving average is $79.17 and its 200 day moving average is $74.97.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm’s revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. CVS Health’s dividend payout ratio (DPR) is 700.00%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.